Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Nanexa NANEXA Apr 24, 2025 1.39 +2.06   
 NanoCap Group B NANOCB Apr 24, 2025 4.98 -4.96   
 NanoEcho NANECH Apr 24, 2025 0.11 +1.13   
 Nanoform Finland NANOFS Apr 24, 2025 11.30 -2.25   
 Nanologica NICA Apr 24, 2025 0.99 -0.60   
 NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI Apr 24, 2025 4 204.60 -0.10   
 NASDAQ OMX Small Cap Sweden PI NOMXSCSE Apr 24, 2025 2 583.35 -0.12   
 Nattaro Labs NATTA Apr 24, 2025 0.42 0.00   
 Navigo Invest AB NAVIGOSTAM Apr 24, 2025 1.84 -4.91   
 Navigo Invest Pref NAVIGOPREF Apr 24, 2025 96.60 +1.68   
 NAXS NAXS Apr 24, 2025 50.82 -1.13   
 NCAB Group NCAB Apr 24, 2025 46.94 -0.72   
 NCC A NCCA Apr 24, 2025 189.00 +1.61   
 NCC B NCCB Apr 24, 2025 188.40 +1.67   
 Nederman Holding NMAN Apr 24, 2025 183.20 +2.58   
 NEL NELO Apr 24, 2025 2.25 -7.92   
 Nelly Group NELLY Apr 24, 2025 39.44 +2.84   
 Neobo Fastigheter NEOBO Apr 24, 2025 17.02 +2.96   
 Neola Medical NEOLA Apr 24, 2025 2.49 -3.49   
 Neovici Holding B NEOB Apr 24, 2025 8.30 -0.48   
 Nepa NEPA Apr 24, 2025 20.10 +0.50   
 Net Insight B NETIB Apr 24, 2025 4.42 -3.07   
 Netel NETEL Apr 24, 2025 11.26 0.00   
 NetJobs Group NJOB Apr 24, 2025 2.92 +32.73   
 New Nordic Healthbrands NNH Apr 24, 2025 14.20 0.00   
 New Wave B NEWAB Apr 24, 2025 108.00 +16.76   
 Newbury Pharmaceuticals NEWBRY Apr 24, 2025 3.23 -2.12   
 Nexam Chemical Holding NEXAM Apr 24, 2025 3.39 +5.94   
 Nexar Group NXAR Apr 24, 2025 0.83 -5.68   
 NextCell Pharma AB NXTCL Apr 24, 2025 1.15 +14.71   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.